Mental illness and psychological wellbeing, from assessment to treatment.
5 companies · 4 products
AI-guided care programmes with clinician oversight for musculoskeletal pain, pelvic and women's health, mental health and cardiometabolic risk, sold to employers, health plans and public systems.
Digital Therapeutics
Health data science company whose NeuroBlu platform provides de-identified longitudinal behavioural-health and neurology records, with an analytics workspace, to life-sciences and research users.
Research Technology
Japanese developer of prescription digital therapeutics: apps for nicotine dependence and hypertension that hold Japanese marketing approval, each prescribed by a physician.
Digital Therapeutics · Based in Japan
Direct-to-consumer AI mental wellbeing app from Sword, launched in March 2026, which the company describes as an AI guide and not a crisis service.
Mental HealthiOSAndroidPrescription therapeutic app and CO checker to assist smoking cessation treatment of patients with nicotine dependence, approved in Japan in 2020.
Digital TherapeuticsiOSAndroidReal-world data platform of de-identified behavioural-health and neurology patient records, with a web application and an analytics workspace in R, Python or SQL.
Research TechnologyWeb
